Vaccination of Patients with Systemic Lupus Erythematosus
10.3904/kjm.2020.95.3.170
- Author:
Chang-Nam SON
1
;
Sang-Hyon KIM
Author Information
1. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
- Publication Type:17
- From:Korean Journal of Medicine
2020;95(3):170-175
- CountryRepublic of Korea
-
Abstract:
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects various organs. SLE patients have an increased risk of infection compared to the general population. Immunosuppressive agents commonly used in SLE increase the risk of infection. Vaccination is a good way to reduce the risk of infection. However, some SLE patients are concerned that vaccination may worsen lupus disease activity or cause side effects. The latest SLE patient vaccination data were reviewed in this study, which focused on the safety, immunogenicity, and efficacy of influenza, pneumococcal, tetanus, hepatitis A, herpes zoster, and human papillomavirus vaccines. Korean immunization recommendations were also compared to those of other countries.
